Test Name |
LH |
Test Code |
513 |
Unit |
mIU/L |
Station |
Chemistry |
CPT Code |
83002 |
Performing Facility |
American Medical Labs, Herzliya |
Analyzer |
Roche cobas 6000 |
Test Method |
Electrochemiluminescence immunoassay |
AML Preferred Tube |
5 mL SST gel |
Storage Instructions |
Refrigerated; 14 days at 2 to 8 oC 6 months at -20 oC , Freeze only once. |
Min. Volume |
1 mL |
Turn-Around-Time |
One day. |
Intended Use |
Immunoassay for the in vitro quantitative determination of luteinizing hormone in human serum and plasma. LH (luteinizing hormone), together with FSH (follicle stimulating hormone), belongs to the gonadotropin family. LH and FSH regulate and stimulate the growth and function of the gonads (ovaries and testes) synergistically.
|
Limitations |
Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration. For diagnostic purposes, the results should always be assessed in conjunction with the patient�s medical history, clinical examination and other findings.
|
Patient Preparation |
No patient preparation needed. |
Reasons for Rejection |
Do not use sodium citrate tube, Improper labelling. |
Adult Reference Ranges |
Men: 1.7 – 8.6 mIU/ml Luteal phase 0-20 mIU/L Midcycle phase 15-80 mIU/L menopausal phase 10-60 mIU/L |